Internal Medicine, Cardiovascular Disease · Wichita, KS
NPI
1780625558
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
3535 N Webb Rd
Wichita, KS, 67226
Phone (316) 686-5300
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.3M
33,014 services
Medicare patients, 2024
5,494
Average age 75
Drug cost, 2024
$6.5M
35,336 prescriptions
Company payments, 2025
$6,648
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Wassim Shaheen was code 99213 (office e&m - established), 4,721 times for 3,719 patients. In total Wassim Shaheen billed 33,014 services in 100 codes, and Medicare paid $3.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-01-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 4,721 | 3,719 | $56.41 | $266K |
| 93000 Electrocardiogram | Office | 4,224 | 3,832 | $8.77 | $37K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 3,793 | 945 | $5.06 | $19K |
| 99214 Office E&M - Established | Office | 2,610 | 2,029 | $92.22 | $241K |
| 93306 Echocardiography (TTE/TEE) | Office | 2,370 | 2,266 | $125.62 | $298K |
| 93296 External Electrocardiographic Monitoring | Office | 1,456 | 468 | $14.38 | $21K |
| A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 1,386 | 687 | $258.11 | $358K |
| 93015 Electrocardiogram | Office | 1,004 | 995 | $47.19 | $47K |
| 93793 Care Management/Coordination | Office | 1,000 | 26 | $7.57 | $7,569 |
| 93294 External Electrocardiographic Monitoring | Office | 955 | 305 | $20.49 | $20K |
| 78431 Myocardial Perfusion Scan | Office | 833 | 832 | $1,693.39 | $1.4M |
| 78434 Myocardial Perfusion Scan | Office | 833 | 832 | $126.30 | $105K |
| 93298 External Electrocardiographic Monitoring | Office | 750 | 103 | $68.90 | $52K |
| 85610 Clinical Chemistry | Office | 744 | 45 | $4.20 | $3,125 |
| 99204 Office E&M - New | Office | 688 | 688 | $105.10 | $72K |
By year: 2022 $2.6M for 30,813 services; 2023 $2.8M for 34,612 services; 2024 $3.3M for 33,014 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 744 | 45 | $4.20 | $3,125 |
Medicare prescription drug claims, 2024
In 2024, the drug Wassim Shaheen prescribed most often to Medicare patients was Eliquis (Apixaban), with 3,943 prescriptions and refills. In total Wassim Shaheen wrote 35,336 Medicare prescriptions that cost $6.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 3,943 | 6,446 | 765 | $3.7M |
| Clopidogrel Clopidogrel Bisulfate | 2,917 | 7,258 | 773 | $20K |
| Atorvastatin Calcium Generic | 2,813 | 7,319 | 760 | $15K |
| Carvedilol Generic | 2,008 | 4,804 | 521 | $10K |
| Amlodipine Besylate Generic | 1,948 | 4,852 | 542 | $9,953 |
| Metoprolol Succinate Generic | 1,945 | 4,520 | 523 | $15K |
| Metoprolol Tartrate Generic | 1,787 | 4,446 | 490 | $7,565 |
| Losartan Potassium Generic | 1,695 | 4,158 | 452 | $11K |
| Lisinopril Generic | 1,493 | 3,661 | 419 | $6,773 |
| Furosemide Generic | 1,313 | 3,038 | 368 | $5,337 |
| Xarelto Rivaroxaban | 933 | 1,745 | 189 | $964K |
| Rosuvastatin Calcium Generic | 851 | 2,019 | 243 | $6,391 |
| Potassium Chloride Generic | 772 | 1,765 | 230 | $13K |
| Entresto Sacubitril/Valsartan | 713 | 1,044 | 129 | $679K |
| Atenolol Generic | 648 | 1,727 | 169 | $2,251 |
Brand drugs: 6,874 claims; generic drugs: 28,462 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Wassim Shaheen $6,648 ($6,648 in general payments such as food, travel and fees) from 17 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $5,159.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 69 | $5,159 |
| Novartis Pharmaceuticals Corporation NVS | 24 | $307 |
| Amgen Inc. AMGN | 11 | $197 |
| Medtronic, Inc. MDT | 2 | $169 |
| Abiomed JNJ | 1 | $147 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 10 | $130 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $87.5 |
| Shockwave Medical, Inc JNJ | 1 | $85.65 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $73.94 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $68.5 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.